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Patel and Wilhelm: Melena with Fever

Melena With Fever
Monica Patel, MD, Resident Department of Internal Medicine 1999-2002
Jennifer Wilhelm, MD, Resident Department of Internal Medicine 1999-2002

The patient is a 62 year old Indian male with a past medical history significant for myasthenia gravis, hypertension, and diabetes mellitus, who presented to an outside
hospital with fever, fecal incontinence, and melena. Work
up at that hospital was remarkable for elevated liver function tests, heme-positive brown stool and a CT of the
abdomen showing a thick ascending colon suggesting
possible mass. The patient had an episode of desaturation
and fever to 105 degrees Fahrenheit prior to transfer to
Thomas Jefferson University Hospital for further evaluation. Upon arrival, the patient was in respiratory distress
with oxygen saturation of 70% on 5 liters of oxygen by
nasal cannula. He was immediately intubated.
The patient was a retired radiologist who emigrated from
southern India 10 years ago. He has no history of tobacco,
alcohol or illicit drug use. There were no known chemical exposures. His myasthenia gravis was diagnosed one
year ago and was treated with pyridostigmine and prednisone. He had been on azathioprine which was discontinued three weeks prior to admission. At the outside
hospital, the patient had been started on ampicillin/sulbactam for empiric coverage secondary to fever and possible infection; pyridostigmine had been discontinued.
Physical exam on admission revealed a temperature of
97.6 degrees Fahrenheit, respiratory rate of 40, regular
pulse of 140 bpm, and blood pressure of 106/70 mm/Hg.
Oxygen saturation was 100% on assist control rate of 16
breaths per minute, tidal volume 600 ml, FiO2 50% and
PEEP of +5. In general, he was a well nourished, medium
build Indian male, intubated and sedated. The patient
had anicteric sclera, pink conjunctiva, no lymphadenopathy, no jugular venous distenstion, no thyromegaly. Heart
rate was tachycardic with regular rhythm. Lung exam
revealed coarse breath sounds bilaterally without
wheezes. Abdomen was soft, non-tender, mildly distended without palpable mass or hepatosplenomegaly.
Rectal exam revealed heme-positive brown stool.
Extremities were warm with bilateral pitting edema.
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Labwork revealed WBC 3,800 /mL (85% neutrophils,
11% bands, 2% lymphocytes), hemoglobin 8.3 grams/dL,
3
platelets 85,000 /mL . The patient had abnormal bicarbonate of 20 mmol/L, elevated blood urea nitrogen (BUN)

of 42 mg/dL, high creatinine of 1.8 mg/dL, and elevated
glucose of 212 mg/dL, His liver function tests were also
abnormal with a low total protein of 4.1 g/dL, low albumin of 2.1 g/dL, and elevated alkaline phosphatase of 246
IU/L, AST of 47 IU/L, ALT of 77 IU/L, and normal total
bilirubin 0.8 mg/dL. Chest x-ray showed mild pulmonary
edema without infiltrate or mass.
The patient’s pancytopenia was thought to be secondary to
myasthenia gravis and he was started on IV immunoglobulin and hydrocortisone. Antibiotic coverage was expanded
to piperacillin/tazobactam. Lower extremity dopplers
revealed no venous thrombosis. CT of chest, abdomen,
pelvis showed chronic wall thickening involving the cecum
and portion of the ascending colon, abdominal ascites, bilateral pleural effusions and diffuse bilateral ground glass
opacities within the lung fields (Figure 1). The patient
underwent bone marrow biopsy for persistent pancytopenia. Results of the biopsy showed necrotizing granulomas
positive for acid fast bacilli. Subsequently, a sputum culture revealed rare acid fast bacilli. MRI of the brain showed
single focus of increased signal intensity in the left inferior
frontal lobe with surrounding edema consistent with tuberculosis. The patient was diagnosed with disseminated
tuberculosis and antituberculosis medications (ethambutol,
pyrazinamide, rifampin, isoniazid) were started.
The patient soon developed melanotic stools. Creatinine
began to rise shortly after intravenous dye load for CT
scan. The patient required multiple transfusions of packed
red blood cells, fresh frozen plasma, and platelets. The
hospital course was further defined by worsening renal
function requiring continuous veno-venous hemodialysis
(CVVHD), continued melena without an identifiable
source requiring frequent transfusions, and persistently
elevated liver function tests despite discontinuation of
rifampin. The patient continued to deteriorate clinically
secondary to multiorgan failure. The family chose to withdraw care and the patient died shortly thereafter.
Discussion
Abdominal tuberculosis is an infrequent diagnosis especially in areas where tuberculosis is uncommon. The diagnosis is often missed because signs and symptoms are
nonspecific with an insidious onset. Pathogenesis of
(Continued on next page)
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abdominal tuberculosis includes swallowing expectorated
sputum in the presence of active tuberculosis, hematogenous spread from pulmonary tuberculosis, ingestion of
unpasteurized milk, or direct extension from adjacent
organs. Common sites of abdominal involvement are the
peritoneum, lymph nodes and ileocecal region. Pathologic
changes involve inflammation of the submucosa and
serosa which leads to edema, lymphatic hyperplasia, and
eventually fibrosis. Mucosal ulceration results from endarteritis of submucosal vessels. Gross pathology is variable
with areas of ulceration (either segmental or diffuse colitis), hypertrophy (polyps or mass), ulcerohypertrophic
(mixed), or intestinal narrowing secondary to fibrous stricture or extraintestinal lymph node compression.
Clinical features are often nonspecific including abdominal pain, diarrhea, and weight loss. Concomitant active
pulmonary tuberculosis is seen in only 15-20% with even
less having a positive PPD test. Complications of abdominal tuberculosis include obstruction secondary to inflammatory thickening, fibrosis, or lymphadenopathy;
perforation; fistula formation; bleeding; and malabsorption secondary to loss of mucosal integrity. The diagnosis
of abdominal tuberculosis relies on maintaining a high
index of suspicion within the appropriate patient population. Active pulmonary tuberculosis should lead the

clinician to consider abdominal tuberculosis in the
patient with concomitant abdominal symptoms.
Radiographic and endoscopic findings are also nonspecific often showing ileocecal involvement with mucosal
ulceration, thickening of the ileocecal valve, strictures,
or segmental narrowing. In order to make the definitive
diagnosis, an endoscopy with biopsy or exploratory
laparotomy is required. Biopsy will show caseating granulomas, with positive culture for acid fast rods.
A therapeutic trial of antitubercular medications may be
appropriate when clinical suspicion is high. The drug
regimens used for treating abdominal tuberculosis are
those used for pulmonary tuberculosis. Treatment course
ranges from 6 to 24 months depending on clinical course.
Importance must be placed on maintaining nutrition.
Surgical intervention is reserved for managing complications of obstruction, perforation, abscess or hemorrhage.
In summary, abdominal tuberculosis continues to be a
diagnostic challenge as signs and symptoms are nonspecific and insidious in onset. Clinicians must maintain a
high index of suspicion within the appropriate patient
population and remember that only up to 20% of
patients will have concomitant pulmonary tuberculosis.

Figure 1. CT scan demonstrating chronic wall thickening involving the
cecum and portion of the ascending colon, abdominal ascites,
bilateral pleural effusions and diffuse bilateral ground glass
opacities within the lung fields.
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